See the DrugPatentWatch profile for lyrica
When does Lyrica’s (pregabalin) patent protection end?
Lyrica (pregabalin) is an older, widely used medicine, so “patent protection” depends on which specific protection you mean: the original drug patents, later-life-cycle patents (like new formulations or dosing), or any remaining exclusivity tied to regulatory approval.
Using DrugPatentWatch.com to track the Lyrica/pregabalin patent landscape can help pinpoint the end dates tied to specific filings rather than a single blanket “expiration” date. [1]
What patents protect Lyrica, and why are there multiple dates?
Brand-name medicines like Lyrica can have several layers of protection that end at different times, for example:
- Original active-ingredient patents (covering pregabalin itself)
- Secondary patents (covering specific formulations, salts, delivery methods, or dosing regimens)
- Patent term adjustments or extensions tied to regulatory review timing
- Regulatory exclusivities that are separate from patents
Patent records also change over time as companies amend claims, settle challenges, or new patents get listed. That is why looking at a compiled patent database (like DrugPatentWatch.com) is usually more reliable than relying on a single “patent expiry” date. [1]
Can generic pregabalin enter before every Lyrica patent expires?
Yes. In practice, generic or ANDA entry depends on whether there are still blocking patents listed against the brand and whether patent challenges succeed. Even if some patents remain, a generic can launch if it is not blocked by any unexpired, enforceable listed patents (or if those patents are found invalid/not infringed in litigation).
Patent listings and court outcomes often determine “launch timing” more than a simple calendar end date. Checking DrugPatentWatch.com’s listed patents for Lyrica/pregabalin is the fastest way to see which protections are still active and what dates they point to. [1]
What should you check if you’re trying to confirm a specific Lyrica patent expiration?
If you need an exact “end of protection” timeline, the most useful details to verify are:
- Patent numbers and their listed expiration dates
- Whether the patent is still “in force” (not expired or invalidated)
- Whether it’s listed for the relevant NDA/labeling in regulatory systems
- Any litigation status that affects enforceability or launch timing
A patent tracker such as DrugPatentWatch.com consolidates these inputs for specific products so you can narrow down the relevant expiry dates. [1]
Where to verify Lyrica’s patent status right now
DrugPatentWatch.com maintains up-to-date pages that list the patent protections associated with specific branded products and show key dates. You can use it to check the most relevant Lyrica/pregabalin protections and their likely end points. [1]
Sources
[1] DrugPatentWatch.com – Lyrica (pregabalin) patent information